The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
3D Bioprinting for Life Science R&D-Global Market Insights and Sales Trends 2024
Synopsis
3D printing first got widespread public attention in 2013, when it was specifically mentioned by President Obama in his State of the Union Address. 3D printing is a manufacturing process where an object is created with the help of a layer-by-layer material approach. Each layer can be considered a thin horizontal cross-section of the final product. It uses Computer Aided Design (CAD) i.e. a digital blueprint to create rapid prototypes, spare parts and final products. 3D printing uses materials like thermoplastics, plastic composites, metals, alloys, ceramics etc. 3D printing as an end-use manufacturing technology is still not fully developed but it has the potential to transform the conception, manufacturing and logistics processes.
The global 3D Bioprinting for Life Science R&D market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of 3D Bioprinting for Life Science R&D in various end use industries. The expanding demands from the Clinical and Research, are propelling 3D Bioprinting for Life Science R&D market. Magnetic 3D Bioprinting, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Laser-Assisted Bioprinting segment is estimated at % CAGR for the next seven-year period.
The drug testing market is likely to be the main driver of the 3D Bioprinting for Life Science R&D Market. Since 2011, a group of U.S government agencies have been investing in something known as ‘Human on a chip’ or ‘Body on a chip’. The objective is to create a miniature human organ system that mimics the bodily response to harmful agents, enabling the development of potential therapies. The pharmaceutical industry could use such equipment to test drugs more efficiently due to human stem cells and at a much lower cost. It would also be less risky.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for 3D Bioprinting for Life Science R&D, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global 3D Bioprinting for Life Science R&D market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global 3D Bioprinting for Life Science R&D market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, 3D Bioprinting for Life Science R&D sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of 3D Bioprinting for Life Science R&D covered in this report include EnvisionTEC, Regenovo, Organovo, 3D Systems, 3D Biotek, Advanced Biomatrix, Digilab and Nano3D Biosciences, etc.
The global 3D Bioprinting for Life Science R&D market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
EnvisionTEC
Regenovo
Organovo
3D Systems
3D Biotek
Advanced Biomatrix
Digilab
Nano3D Biosciences
Global 3D Bioprinting for Life Science R&D market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global 3D Bioprinting for Life Science R&D market, Segment by Type:
Magnetic 3D Bioprinting
Laser-Assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting
Global 3D Bioprinting for Life Science R&D market, by Application
Clinical
Research
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of 3D Bioprinting for Life Science R&D companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
3D printing first got widespread public attention in 2013, when it was specifically mentioned by President Obama in his State of the Union Address. 3D printing is a manufacturing process where an object is created with the help of a layer-by-layer material approach. Each layer can be considered a thin horizontal cross-section of the final product. It uses Computer Aided Design (CAD) i.e. a digital blueprint to create rapid prototypes, spare parts and final products. 3D printing uses materials like thermoplastics, plastic composites, metals, alloys, ceramics etc. 3D printing as an end-use manufacturing technology is still not fully developed but it has the potential to transform the conception, manufacturing and logistics processes.
The global 3D Bioprinting for Life Science R&D market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of 3D Bioprinting for Life Science R&D in various end use industries. The expanding demands from the Clinical and Research, are propelling 3D Bioprinting for Life Science R&D market. Magnetic 3D Bioprinting, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Laser-Assisted Bioprinting segment is estimated at % CAGR for the next seven-year period.
The drug testing market is likely to be the main driver of the 3D Bioprinting for Life Science R&D Market. Since 2011, a group of U.S government agencies have been investing in something known as ‘Human on a chip’ or ‘Body on a chip’. The objective is to create a miniature human organ system that mimics the bodily response to harmful agents, enabling the development of potential therapies. The pharmaceutical industry could use such equipment to test drugs more efficiently due to human stem cells and at a much lower cost. It would also be less risky.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for 3D Bioprinting for Life Science R&D, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global 3D Bioprinting for Life Science R&D market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global 3D Bioprinting for Life Science R&D market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, 3D Bioprinting for Life Science R&D sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of 3D Bioprinting for Life Science R&D covered in this report include EnvisionTEC, Regenovo, Organovo, 3D Systems, 3D Biotek, Advanced Biomatrix, Digilab and Nano3D Biosciences, etc.
The global 3D Bioprinting for Life Science R&D market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
EnvisionTEC
Regenovo
Organovo
3D Systems
3D Biotek
Advanced Biomatrix
Digilab
Nano3D Biosciences
Global 3D Bioprinting for Life Science R&D market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global 3D Bioprinting for Life Science R&D market, Segment by Type:
Magnetic 3D Bioprinting
Laser-Assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting
Global 3D Bioprinting for Life Science R&D market, by Application
Clinical
Research
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of 3D Bioprinting for Life Science R&D companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of 3D Bioprinting for Life Science R&D
1.1 3D Bioprinting for Life Science R&D Market Overview
1.1.1 3D Bioprinting for Life Science R&D Product Scope
1.1.2 3D Bioprinting for Life Science R&D Market Status and Outlook
1.2 Global 3D Bioprinting for Life Science R&D Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global 3D Bioprinting for Life Science R&D Market Size by Region (2018-2029)
1.4 Global 3D Bioprinting for Life Science R&D Historic Market Size by Region (2018-2023)
1.5 Global 3D Bioprinting for Life Science R&D Market Size Forecast by Region (2024-2029)
1.6 Key Regions, 3D Bioprinting for Life Science R&D Market Size (2018-2029)
1.6.1 North America 3D Bioprinting for Life Science R&D Market Size (2018-2029)
1.6.2 Europe 3D Bioprinting for Life Science R&D Market Size (2018-2029)
1.6.3 Asia-Pacific 3D Bioprinting for Life Science R&D Market Size (2018-2029)
1.6.4 Latin America 3D Bioprinting for Life Science R&D Market Size (2018-2029)
1.6.5 Middle East & Africa 3D Bioprinting for Life Science R&D Market Size (2018-2029)
2 3D Bioprinting for Life Science R&D Market by Type
2.1 Introduction
2.1.1 Magnetic 3D Bioprinting
2.1.2 Laser-Assisted Bioprinting
2.1.3 Inkjet 3D Bioprinting
2.1.4 Microextrusion 3D Bioprinting
2.2 Global 3D Bioprinting for Life Science R&D Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global 3D Bioprinting for Life Science R&D Historic Market Size by Type (2018-2023)
2.2.2 Global 3D Bioprinting for Life Science R&D Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America 3D Bioprinting for Life Science R&D Revenue Breakdown by Type (2018-2029)
2.3.2 Europe 3D Bioprinting for Life Science R&D Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific 3D Bioprinting for Life Science R&D Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America 3D Bioprinting for Life Science R&D Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa 3D Bioprinting for Life Science R&D Revenue Breakdown by Type (2018-2029)
3 3D Bioprinting for Life Science R&D Market Overview by Application
3.1 Introduction
3.1.1 Clinical
3.1.2 Research
3.2 Global 3D Bioprinting for Life Science R&D Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global 3D Bioprinting for Life Science R&D Historic Market Size by Application (2018-2023)
3.2.2 Global 3D Bioprinting for Life Science R&D Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America 3D Bioprinting for Life Science R&D Revenue Breakdown by Application (2018-2029)
3.3.2 Europe 3D Bioprinting for Life Science R&D Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific 3D Bioprinting for Life Science R&D Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America 3D Bioprinting for Life Science R&D Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa 3D Bioprinting for Life Science R&D Revenue Breakdown by Application (2018-2029)
4 3D Bioprinting for Life Science R&D Competition Analysis by Players
4.1 Global 3D Bioprinting for Life Science R&D Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in 3D Bioprinting for Life Science R&D as of 2022)
4.3 Date of Key Players Enter into 3D Bioprinting for Life Science R&D Market
4.4 Global Top Players 3D Bioprinting for Life Science R&D Headquarters and Area Served
4.5 Key Players 3D Bioprinting for Life Science R&D Product Solution and Service
4.6 Competitive Status
4.6.1 3D Bioprinting for Life Science R&D Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 EnvisionTEC
5.1.1 EnvisionTEC Profile
5.1.2 EnvisionTEC Main Business
5.1.3 EnvisionTEC 3D Bioprinting for Life Science R&D Products, Services and Solutions
5.1.4 EnvisionTEC 3D Bioprinting for Life Science R&D Revenue (US$ Million) & (2018-2023)
5.1.5 EnvisionTEC Recent Developments
5.2 Regenovo
5.2.1 Regenovo Profile
5.2.2 Regenovo Main Business
5.2.3 Regenovo 3D Bioprinting for Life Science R&D Products, Services and Solutions
5.2.4 Regenovo 3D Bioprinting for Life Science R&D Revenue (US$ Million) & (2018-2023)
5.2.5 Regenovo Recent Developments
5.3 Organovo
5.3.1 Organovo Profile
5.3.2 Organovo Main Business
5.3.3 Organovo 3D Bioprinting for Life Science R&D Products, Services and Solutions
5.3.4 Organovo 3D Bioprinting for Life Science R&D Revenue (US$ Million) & (2018-2023)
5.3.5 3D Systems Recent Developments
5.4 3D Systems
5.4.1 3D Systems Profile
5.4.2 3D Systems Main Business
5.4.3 3D Systems 3D Bioprinting for Life Science R&D Products, Services and Solutions
5.4.4 3D Systems 3D Bioprinting for Life Science R&D Revenue (US$ Million) & (2018-2023)
5.4.5 3D Systems Recent Developments
5.5 3D Biotek
5.5.1 3D Biotek Profile
5.5.2 3D Biotek Main Business
5.5.3 3D Biotek 3D Bioprinting for Life Science R&D Products, Services and Solutions
5.5.4 3D Biotek 3D Bioprinting for Life Science R&D Revenue (US$ Million) & (2018-2023)
5.5.5 3D Biotek Recent Developments
5.6 Advanced Biomatrix
5.6.1 Advanced Biomatrix Profile
5.6.2 Advanced Biomatrix Main Business
5.6.3 Advanced Biomatrix 3D Bioprinting for Life Science R&D Products, Services and Solutions
5.6.4 Advanced Biomatrix 3D Bioprinting for Life Science R&D Revenue (US$ Million) & (2018-2023)
5.6.5 Advanced Biomatrix Recent Developments
5.7 Digilab
5.7.1 Digilab Profile
5.7.2 Digilab Main Business
5.7.3 Digilab 3D Bioprinting for Life Science R&D Products, Services and Solutions
5.7.4 Digilab 3D Bioprinting for Life Science R&D Revenue (US$ Million) & (2018-2023)
5.7.5 Digilab Recent Developments
5.8 Nano3D Biosciences
5.8.1 Nano3D Biosciences Profile
5.8.2 Nano3D Biosciences Main Business
5.8.3 Nano3D Biosciences 3D Bioprinting for Life Science R&D Products, Services and Solutions
5.8.4 Nano3D Biosciences 3D Bioprinting for Life Science R&D Revenue (US$ Million) & (2018-2023)
5.8.5 Nano3D Biosciences Recent Developments
6 North America
6.1 North America 3D Bioprinting for Life Science R&D Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe 3D Bioprinting for Life Science R&D Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific 3D Bioprinting for Life Science R&D Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America 3D Bioprinting for Life Science R&D Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa 3D Bioprinting for Life Science R&D Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 3D Bioprinting for Life Science R&D Market Dynamics
11.1 3D Bioprinting for Life Science R&D Industry Trends
11.2 3D Bioprinting for Life Science R&D Market Drivers
11.3 3D Bioprinting for Life Science R&D Market Challenges
11.4 3D Bioprinting for Life Science R&D Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
